1. Home
  2. VMD vs SENS Comparison

VMD vs SENS Comparison

Compare VMD & SENS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viemed Healthcare Inc.

VMD

Viemed Healthcare Inc.

HOLD

Current Price

$9.10

Market Cap

465.4M

Sector

N/A

ML Signal

HOLD

Logo Senseonics Holdings Inc.

SENS

Senseonics Holdings Inc.

N/A

Current Price

$9.70

Market Cap

496.0M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
VMD
SENS
Founded
2006
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
465.4M
496.0M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
VMD
SENS
Price
$9.10
$9.70
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$18.38
AVG Volume (30 Days)
413.2K
808.9K
Earning Date
05-05-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
32.14
N/A
EPS
0.13
N/A
Revenue
$270,280,000.00
$16,389,000.00
Revenue This Year
$17.88
$74.15
Revenue Next Year
$14.98
$58.60
P/E Ratio
$69.15
N/A
Revenue Growth
20.52
19.85
52 Week Low
$6.05
$0.41
52 Week High
$12.61
$10.15

Technical Indicators

Market Signals
Indicator
VMD
SENS
Relative Strength Index (RSI) 37.89 69.40
Support Level $8.49 $5.13
Resistance Level $10.05 $9.99
Average True Range (ATR) 0.28 0.56
MACD 0.07 -0.01
Stochastic Oscillator 54.55 79.25

Price Performance

Historical Comparison
VMD
SENS

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.

About SENS Senseonics Holdings Inc.

Senseonics Holdings Inc is a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Its implantable CGM system, Eversense, including Eversense E3 and Eversense 365 CGM systems, measures glucose levels via an under-the-skin sensor, a removable and rechargeable smart transmitter, and an app for real-time diabetes monitoring and management. The company operates through one reportable segment which derives its revenues from diabetes products and services and generates the majority of its revenue from the United States.

Share on Social Networks: